# PRO#0118: Decitabine Plus Mini Flu-Bu

> **NCT01455506** · PHASE1 · COMPLETED · sponsor: **Hackensack Meridian Health** · enrollment: 20 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Decitabine plus Fludarabine and Busulfan

## Key facts

- **NCT ID:** NCT01455506
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455506, "PRO#0118: Decitabine Plus Mini Flu-Bu". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01455506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*